Most recently, Yuvraj was the Director of Operations, Business Development & Process Excellence at Zeon Lifesciences Ltd
Nitrosamines have prompted evolving global guidelines that demand rigorous industry oversight
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
This collaboration turns kitting into a strategic advantage for sponsors and sites
The successful refinancing and enhancement of the syndicated credit facilities provides access to an additional CHF 40 million
Syngene International has reported total income of Rs. 926 crore during the period ended September 30, 2025
The FDA’s review also revealed delays in Philips’ internal investigations, with 54 inquiries failing to meet targeted completion dates—23 of which were delayed by more than 100 days
The quarter included three IPOs worth US$ 428 million and one Qualified Institutional Placement (QIP) worth US$ 88 million
The antibody was designed and developed at Abzena’s Cambridge, UK,
Subscribe To Our Newsletter & Stay Updated
